Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2009-06-27 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: FONTAINE-LA-GUYON (28190), Eure-et-Loir
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
S.E.L.A.R.L. PHARMACIE COLIN : revenue, balance sheet and financial ratios
S.E.L.A.R.L. PHARMACIE COLIN is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in FONTAINE-LA-GUYON (28190),
this company of category PME
shows in 2024 a net income positive of 98 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - S.E.L.A.R.L. PHARMACIE COLIN (SIREN 513710087)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
98 146 €
113 204 €
163 634 €
175 509 €
118 580 €
120 889 €
57 125 €
109 162 €
108 487 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, S.E.L.A.R.L. PHARMACIE COLIN generates positive net income of 98 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 108 k€ -> 98 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
98 146 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 11%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 85%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
10.627%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
84.618%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution S.E.L.A.R.L. PHARMACIE COLIN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
125.214
90.667
70.131
54.06
36.666
21.794
13.047
5.417
10.627
Financial autonomy
40.291
47.138
52.957
58.705
65.863
71.338
79.608
85.042
84.618
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
10.632024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of S.E.L.A.R.L. PHARMACIE COLIN (10.63) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
84.62%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+10 pts over 3 years
In 2024, the financial autonomy of S.E.L.A.R.L. PHARMACIE COLIN (84.6%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 567.06. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
567.062
Liquidity indicators evolution S.E.L.A.R.L. PHARMACIE COLIN
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
278.41
266.503
258.903
315.872
319.427
289.139
391.277
391.548
567.062
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
567.062024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent
In 2024, the liquidity ratio of S.E.L.A.R.L. PHARMACIE COLIN (567.06) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution S.E.L.A.R.L. PHARMACIE COLIN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
0
Customer payment term (days)
183
228
0
0
0
0
0
0
0
Supplier payment term (days)
476
755
0
0
0
0
0
0
0
Positioning of S.E.L.A.R.L. PHARMACIE COLIN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of S.E.L.A.R.L. PHARMACIE COLIN is estimated at
1 370 190 €
(range 954 179€ - 2 049 883€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
954k€1370k€2049k€
1 370 190 €Range: 954 179€ - 2 049 883€
NAF 5 année 2024
Valuation method used
Net Income Multiple
98 146 €
×
14.0x
=1 370 191 €
Range: 954 179€ - 2 049 884€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare S.E.L.A.R.L. PHARMACIE COLIN with other companies in the same sector:
Frequently asked questions about S.E.L.A.R.L. PHARMACIE COLIN
What is the revenue of S.E.L.A.R.L. PHARMACIE COLIN ?
The revenue of S.E.L.A.R.L. PHARMACIE COLIN is not publicly disclosed (confidential accounts filed with INPI).
Is S.E.L.A.R.L. PHARMACIE COLIN profitable?
Yes, S.E.L.A.R.L. PHARMACIE COLIN generated a net profit of 98 k€ in 2024.
Where is the headquarters of S.E.L.A.R.L. PHARMACIE COLIN ?
The headquarters of S.E.L.A.R.L. PHARMACIE COLIN is located in FONTAINE-LA-GUYON (28190), in the department Eure-et-Loir.
Where to find the tax return of S.E.L.A.R.L. PHARMACIE COLIN ?
The tax return of S.E.L.A.R.L. PHARMACIE COLIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does S.E.L.A.R.L. PHARMACIE COLIN operate?
S.E.L.A.R.L. PHARMACIE COLIN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart